Intertek discuss advanced testing approaches at Respiratory Drug Delivery (RDD) Asia 2018

Discuss strategic approaches to inhalation product characterisation during Respiratory Drug Delivery Asia (RDD Asia) 2018 Conference, Kerala, India, November 14-16, 2018

During the Respiratory Drug Delivery Asia (RDD Asia) 2018 Conference our inhalation product development experts will provide updates on the latest developments in our inhaled product development capabilities for nasal sprays, dry powder inhalers (DPIs), metered dose inhalers (MDIs) and nebulisers.

Our experts provide integrated OINDP development and testing services for both small molecules and biologics through its centres of excellence in Melbourn, Cambridge, UK. We provide critical performance and quality testing such as laser particle sizing, aerodynamic particle size distribution (APSD) by impaction (ACI, NGI) and spray pattern/plume geometry. Intertek’s integrated formulation development and analytical teams carry out early stage pre-formulation support, solubility screening, drug-excipient compatibility, stability testing and device selection support. For large molecule development, comprehensive protein characterisation services supported by forced degradation and stability monitoring for the protein’s structure and bioactivity throughout formulation and storage can also be provided. Interaction with the device and closure systems are evaluated through comprehensive extractable and leachable testing and toxicological assessments.


WEBINAR REGISTRATION IS OPEN: Advanced analytical techniques for the testing of generic orally inhaled and nasal drug products


BROCHURE: Intertek Inhaled Product Development Brochure

WHITE PAPER: Formulation of Biologics for Inhaled and Nasal Delivery

WEBINAR ON DEMAND: Formulation Strategies for Orally Inhaled and Nasal Drug Products

RDD Asia offers attendees the opportunity to participate in one of the largest and most focussed international conferences on respiratory drug delivery in Asia. It will feature industry updates, in-depth presentations and discussion of pioneering respiratory drug delivery science relating to pMDIs, DPIs, nebulizers, nasal sprays and emerging aerosol delivery platforms.
Expert speakers will cover topics including new therapeutic opportunities and drug delivery technologies, novel in vitro clinical testing methods and new regulatory insight during the conference program or workshop sessions.
Need help or have a question? +1 800 967 5352

Need help or have a question?

+1 800 967 5352
+44 161 721 5247
+41 61 686 4800


Intertek Inhaled Product Development Brochure

White Paper:

Formulation of Biologics for Inhaled and Nasal Delivery

Fact Sheet: